pharmaphorum

SEPTEMBER 30, 2022

Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug for another few years. billion in the first half of 2022.

Diabetes 59

Diabetes Vaccines 59

PharmaShots

APRIL 13, 2023

by the sales of Humira 2006 Johnson & Johnson recorded global sales of $53.3B in the year 2006, thereby depicting a growth rate of 5.6%. in revenue following the addition of Pfizer’s consumer health business in the year 2006. in revenue following the addition of Pfizer’s consumer health business in the year 2006.

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

MAY 20, 2022

Coordinating and delivering clinical research has been a central focus of the NIHR since the organisation was first established in 2006. Her work supporting vaccine trials in particular has spanned in healthcare settings beyond the hospital clinic, including primary care and the wider health a care environments.

Hospitals 59

Hospitals Medical Records Vaccines Diabetes 59

pharmaphorum

FEBRUARY 26, 2021

During this tenure, J&J entered into the areas of vision care, mechanical wound closure and diabetes management. In 2006, J&J acquired Pfizer Consumer Healthcare for $16.6 Acquisitions post-Janssen. Between 1976 and 1989, James E. Burke was chairman and CEO of J&J. billion in cash.

Vaccines 126

Vaccines Biosimilars Labelling Communication 126

pharmaphorum

DECEMBER 2, 2020

Others rapidly followed, including Glucotrol, aimed at diabetics, and Procardia, an anti-hypertensive. One thing that highlighted this changed focus was the appointment of Kindler as CEO in 2006. The 1990s and 2000s would soon take this blockbuster-based success to new levels.

Compounding 128

Compounding Vaccines Biosimilars Diabetes 128

Express Pharma

JANUARY 3, 2025

In 2006, he started Epygen Labs, with its headquarters based in Dubiotech Park, Dubai, UAE, focusing on industrial biotechnology. While shortlisting possibilities to expand back in India, he was approached by the UAE government, which was looking to start the Dubiotech Park, Dubai. Omicron BA.5).

Biosimilars 105

Biosimilars Vaccines Diabetes 105